LGND

NASDAQ · Pharmaceuticals

Ligand Pharmaceuticals

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$299.04

+0.63 (+0.21%)

As of Sep 24, 9:57 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target -89.4% upside

Low Target $18.80

Average Target $31.56

High Target $35.41

Current Price $299.04

Current
$299.04

Target
$31.56

$18.80 $31.56 avg $35.41

Scenario Analysis

Bear Case

$18.80

-93.7%

Low target

Base Case

$31.56

-89.4%

Avg target

Bull Case

$35.41

+-88.2%

High target

Risk/Reward

0.9x

Unfavorable

Price in Context

52-Week High

$326.63

-8.4% from high

52-Week Low

$163.45

+83.0% from low

50-Day SMA

$193.47

+54.6% vs SMA

200-Day SMA

$162.08

+84.5% vs SMA

RSI (14)

38.7

Neutral

Target vs 52W High

$31.56

-90.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.6%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+10.7%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+7.6%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+19.3%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+183.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.8%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+198.7%